Yves Leurquin is a seasoned business leader and vaccine expert with more than 30 years of experience in Marketing, Sales, and Government Affairs. His unique strengths include identifying new business opportunities, acquiring companies, and then developing and launching new vaccines in collaboration with public sector clients. Prior to Inventprise, Yves held senior leadership positions in Commercial & Govt. Affairs at Takeda Pharmaceuticals Int., GSK Biologicals, and Janssen. He also served as EVP of Int’l. and Gov’t. Affairs at Johnson & Johnson (Crucell), where he led engagements with UN organizations and was responsible for commercial interests in Latin America, Middle East, Africa and Asia.
In his current role, Yves Leurquin leads partnerships, capital formation, and structural growth at Inventprise, which is currently focused on bringing their 25-valent pneumococcal conjugate vaccine to market. A Belgian native, Yves now resides in Washington. He holds a BS degree in Computer & Human Sciences from Université libre de Bruxelles and a Master’s degree in Business Engineering from ICHEC Brussels Management School.